Unionview LLC’s iShares MSCI Emerging Markets ETF EEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.27M Sell
30,258
-238
-0.8% -$10.5K 0.93% 21
2024
Q3
$1.4M Sell
30,496
-5,094
-14% -$220K 1.09% 21
2024
Q2
$1.52M Sell
35,590
-11,278
-24% -$473K 1.24% 19
2024
Q1
$1.93M Sell
46,868
-2,517
-5% -$100K 1.59% 16
2023
Q4
$1.99M Buy
49,385
+1,037
+2% +$40K 1.78% 15
2023
Q3
$1.83M Buy
48,348
+62
+0.1% +$2.46K 1.73% 15
2023
Q2
$1.91M Sell
48,286
-1,030
-2% -$40.5K 1.74% 14
2023
Q1
$1.95M Buy
49,316
+248
+0.5% +$9.86K 1.83% 13
2022
Q4
$1.86M Sell
49,068
-3,112
-6% -$115K 1.86% 14
2022
Q3
$1.82M Buy
52,180
+9,888
+23% +$386K 2.08% 12
2022
Q2
$1.7M Buy
42,292
+5,466
+15% +$229K 1.89% 13
2022
Q1
$1.66M Buy
36,826
+7,903
+27% +$373K 1.55% 13
2021
Q4
$1.41M Buy
+28,923
New +$1.46M 1.32% 16

Other funds holding EEM

Unionview LLC's EEM Position: Q4 2024 in Review

Unionview LLC reduced its iShares MSCI Emerging Markets ETF (EEM) stake by 0.78% in Q4 2024, selling an estimated $10.5K and leaving 30,258 shares worth $1.27M. The position accounts for 0.93% of the portfolio, ranked #21.

Unionview LLC first reported a position in EEM in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.99M in Q4 2023. 1,326 funds tracked by Wall St. Rank hold EEM as of Q4 2024.

  • Unionview LLC held 30,258 shares of iShares MSCI Emerging Markets ETF worth $1.27M as of Q4 2024.
  • Unionview LLC sold 238 iShares MSCI Emerging Markets ETF shares in Q4 2024, an estimated $10.5K.
  • iShares MSCI Emerging Markets ETF made up 0.93% of Unionview LLC's portfolio in Q4 2024, its #21 holding.
  • Unionview LLC first reported a position in iShares MSCI Emerging Markets ETF in Q4 2021 and has held it in 13 quarters since.
  • Unionview LLC's iShares MSCI Emerging Markets ETF position peaked at $1.99M in Q4 2023.
  • 1,326 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ETF as of Q4 2024.

Based on Unionview LLC's 13F filing for Q4 2024, filed 3 Feb 2025.